![[Updated] Healthtech firm Biofourmis to earn unicorn status with General Atlantic funding](https://media.dealstreetasia.com/uploads/2022/04/doctor.jpg?fit=978,555&resize=1920,undefined&q=75)
Digital therapeutics firm Biofourmis, which was founded in Singapore, is set to bag new funding from growth equity firm General Atlantic in a deal that will value it at over $1 billion, according to two sources familiar with the matter.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
